JA Onomichi General Hospital

Japan Culture and Welfare Federation of Agricultural Cooperatives

Pancreatic Cancer

Cosomil, Inc.

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This nationwide, multicenter, prospective, single-arm interventional feasibility study evaluates the Enzeavour Pancreatic Cancer assay in routine health checkups and cancer screening in Japan. Approximately 10,000 asymptomatic adults will be enrolled. Participants with an Enzeavour Score above 0.369 will undergo diagnostic work-up as clinically indicated. The primary outcome is pancreatic cancer detection rate within 12 months after the index blood draw, and the secondary outcome is positive predictive value.

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

Japan Culture and Welfare Federation of Agricultural Cooperatives | JA Onomichi General Hospital

Site insights

Work at this site?

Active trials

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan (ENZEAVOUR FS)

Trial sponsors